ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alzheimer’s drug designed using Exscientia’s AI technology enters clinic
May 17, 2021An Alzheimer’s disease drug candidate designed using Exscientia’s artificial intelligence (AI) technology has entered Phase I clinical testing, the company announced May 13. -
First AI designed Alzheimer’s drug to enter clinical trials
May 14, 2021The trial of DSP-0038, an Alzheimer’s disease psychosis drug designed using artificial intelligence, will assess its ability to improve the behavioural and psychological symptoms of dementia.
Pharma Sources Insight January 2025
